Table of Contents Author Guidelines Submit a Manuscript
Neural Plasticity
Volume 2016, Article ID 2754078, 12 pages
http://dx.doi.org/10.1155/2016/2754078
Review Article

Hypothalamic AMPK as a Regulator of Energy Homeostasis

Departments of Pharmacology and Global Medical Science, Wonju College of Medicine, Yonsei University, Wonju 26426, Republic of Korea

Received 22 April 2016; Accepted 10 July 2016

Academic Editor: Edgar Soria-Gomez

Copyright © 2016 My Khanh Q. Huynh et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. C. Kennedy, “The central nervous regulation of calorie balance,” Proceedings of the Nutrition Society, vol. 20, pp. 58–64, 1961. View at Publisher · View at Google Scholar · View at Scopus
  2. G. A. Bray, “Regulation of energy balance: studies on genetic, hypothalamic and dietary obesity,” Proceedings of the Nutrition Society, vol. 41, no. 2, pp. 95–108, 1982. View at Publisher · View at Google Scholar · View at Scopus
  3. S. C. Woods, R. J. Seeley, D. Porte Jr., and M. W. Schwartz, “Signals that regulate food intake and energy homeostasis,” Science, vol. 280, no. 5368, pp. 1378–1383, 1998. View at Publisher · View at Google Scholar · View at Scopus
  4. C. C. Cheung, D. K. Clifton, and R. A. Steiner, “Proopiomelanocortin neurons are direct targets for leptin in the hypothalamus,” Endocrinology, vol. 138, no. 10, pp. 4489–4492, 1997. View at Publisher · View at Google Scholar · View at Scopus
  5. J. G. Mercer, N. Hoggard, L. M. Williams et al., “Coexpression of leptin receptor and preproneuropeptide Y mRNA in arcuate nucleus of mouse hypothalamus,” Journal of Neuroendocrinology, vol. 8, no. 10, pp. 733–735, 1996. View at Publisher · View at Google Scholar · View at Scopus
  6. M. M. Ollmann, B. D. Wilson, Y.-K. Yang et al., “Antagonism of central melanocortin receptors in vitro and in vivo by agouti-related protein,” Science, vol. 278, no. 5335, pp. 135–138, 1997. View at Publisher · View at Google Scholar · View at Scopus
  7. Y. Aponte, D. Atasoy, and S. M. Sternson, “AGRP neurons are sufficient to orchestrate feeding behavior rapidly and without training,” Nature Neuroscience, vol. 14, no. 3, pp. 351–355, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. N. Wu, B. Zheng, A. Shaywitz et al., “AMPK-dependent degradation of TXNIP upon energy stress leads to enhanced glucose uptake via GLUT1,” Molecular Cell, vol. 49, no. 6, pp. 1167–1175, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. C. J. Estler and H. P. Ammon, “The importance of the adrenergic beta-receptors for thermogenesis and survival of acutely cold-exposed mice,” Canadian Journal of Physiology and Pharmacology, vol. 47, no. 5, pp. 427–434, 1969. View at Publisher · View at Google Scholar · View at Scopus
  10. D. G. Hardie and D. Carling, “The AMP-activated protein kinase—fuel gauge of the mammalian cell?” European Journal of Biochemistry, vol. 246, no. 2, pp. 259–273, 1997. View at Publisher · View at Google Scholar · View at Scopus
  11. F. Moore, J. Weekes, and D. G. Hardie, “Evidence that AMP triggers phosphorylation as well as direct allosteric activation of rat liver AMP-activated protein kinase. A sensitive mechanism to protect the cell against ATP depletion,” European Journal of Biochemistry, vol. 199, no. 3, pp. 691–697, 1991. View at Publisher · View at Google Scholar · View at Scopus
  12. D. G. Hardie, “AMP-activated/SNF1 protein kinases: conserved guardians of cellular energy,” Nature Reviews Molecular Cell Biology, vol. 8, no. 10, pp. 774–785, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. A.-S. Marsin, L. Bertrand, M. H. Rider et al., “Phosphorylation and activation of heart PFK-2 by AMPK has a role in the stimulation of glycolysis during ischaemia,” Current Biology, vol. 10, no. 20, pp. 1247–1255, 2000. View at Publisher · View at Google Scholar · View at Scopus
  14. A.-S. Marsin, C. Bouzin, L. Bertrand, and L. Hue, “The stimulation of glycolysis by hypoxia in activated monocytes is mediated by AMP-activated protein kinase and inducible 6-phosphofructo-2-kinase,” The Journal of Biological Chemistry, vol. 277, no. 34, pp. 30778–30783, 2002. View at Publisher · View at Google Scholar · View at Scopus
  15. S. P. Berasi, C. Huard, D. Li et al., “Inhibition of gluconeogenesis through transcriptional activation of EGR1 and DUSP4 by AMP-activated kinase,” The Journal of Biological Chemistry, vol. 281, no. 37, pp. 27167–27177, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. S. Horman, G. J. Browne, U. Krause et al., “Activation of AMP-activated protein kinase leads to the phosphorylation of elongation factor 2 and an inhibition of protein synthesis,” Current Biology, vol. 12, no. 16, pp. 1419–1423, 2002. View at Publisher · View at Google Scholar · View at Scopus
  17. P. R. Clarke and D. G. Hardie, “Regulation of HMG-CoA reductase: identification of the site phosphorylated by the AMP-activated protein kinase in vitro and in intact rat liver,” The EMBO Journal, vol. 9, no. 8, pp. 2439–2446, 1990. View at Google Scholar · View at Scopus
  18. D. M. Muoio, K. Seefeld, L. A. Witters, and R. A. Coleman, “AMP-activated kinase reciprocally regulates triacylglycerol synthesis and fatty acid oxidation in liver and muscle: evidence that sn-glycerol-3-phosphate acyltransferase is a novel target,” Biochemical Journal, vol. 338, no. 3, pp. 783–791, 1999. View at Publisher · View at Google Scholar · View at Scopus
  19. M. López, R. Nogueiras, M. Tena-Sempere, and C. Diéguez, “Hypothalamic AMPK: a canonical regulator of whole-body energy balance,” Nature Reviews Endocrinology, vol. 12, no. 7, pp. 421–432, 2016. View at Publisher · View at Google Scholar
  20. Y. Minokoshi, T. Alquier, H. Furukawa et al., “AMP-kinase regulates food intake by responding to hormonal and nutrient signals in the hypothalamus,” Nature, vol. 428, no. 6982, pp. 569–574, 2004. View at Publisher · View at Google Scholar · View at Scopus
  21. J. Bass and J. S. Takahashi, “Circadian integration of metabolism and energetics,” Science, vol. 330, no. 6009, pp. 1349–1354, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. L. E. Landree, A. L. Hanlon, D. W. Strong et al., “C75, a fatty acid synthase inhibitor, modulates AMP-activated protein kinase to alter neuronal energy Metabolism,” The Journal of Biological Chemistry, vol. 279, no. 5, pp. 3817–3827, 2004. View at Publisher · View at Google Scholar · View at Scopus
  23. M. S. Kim and K. U. Lee, “Role of hypothalamic 5′-AMP-activated protein kinase in the regulation of food intake and energy homeostasis,” Journal of Molecular Medicine, vol. 83, no. 7, pp. 514–520, 2005. View at Publisher · View at Google Scholar · View at Scopus
  24. D. Stapleton, K. I. Mitchelhill, G. Gao et al., “Mammalian AMP-activated protein kinase subfamily,” The Journal of Biological Chemistry, vol. 271, no. 2, pp. 611–614, 1996. View at Publisher · View at Google Scholar · View at Scopus
  25. D. Stapleton, E. Woollatt, K. I. Mitchelhill et al., “AMP-activated protein kinase isoenzyme family: subunit structure and chromosomal location,” FEBS Letters, vol. 409, no. 3, pp. 452–456, 1997. View at Publisher · View at Google Scholar · View at Scopus
  26. P. C. F. Cheung, I. P. Salt, S. P. Davies, D. G. Hardie, and D. Carling, “Characterization of AMP-activated protein kinase γ-subunit isoforms and their role in AMP binding,” Biochemical Journal, vol. 346, no. 3, pp. 659–669, 2000. View at Publisher · View at Google Scholar · View at Scopus
  27. E. R. Hudson, D. A. Pan, J. James et al., “A novel domain in AMP-activated protein kinase causes glycogen storage bodies similar to those seen in hereditary cardiac arrhythmias,” Current Biology, vol. 13, no. 10, pp. 861–866, 2003. View at Publisher · View at Google Scholar · View at Scopus
  28. A. Bateman, “The structure of a domain common to archaebacteria and the homocystinuria disease protein,” Trends in Biochemical Sciences, vol. 22, no. 1, pp. 12–13, 1997. View at Publisher · View at Google Scholar · View at Scopus
  29. M. C. Towler and D. G. Hardie, “AMP-activated protein kinase in metabolic control and insulin signaling,” Circulation Research, vol. 100, no. 3, pp. 328–341, 2007. View at Publisher · View at Google Scholar · View at Scopus
  30. M. Vogel and F. Heinz, “Purification and characterisation of the cyclic amp-dependent protein kinase, the C- and the R-protein from bovine liver,” Biochimica et Biophysica Acta (BBA)—Protein Structure, vol. 670, no. 1, pp. 47–55, 1981. View at Publisher · View at Google Scholar · View at Scopus
  31. G. J. Gowans, S. A. Hawley, F. A. Ross, and D. G. Hardie, “AMP is a true physiological regulator of amp-activated protein kinase by both allosteric activation and enhancing net phosphorylation,” Cell Metabolism, vol. 18, no. 4, pp. 556–566, 2013. View at Publisher · View at Google Scholar · View at Scopus
  32. D. Carling, C. Thornton, A. Woods, and M. J. Sanders, “AMP-activated protein kinase: new regulation, new roles?” Biochemical Journal, vol. 445, no. 1, pp. 11–27, 2012. View at Publisher · View at Google Scholar · View at Scopus
  33. S. A. Hawley, M. Davison, A. Woods et al., “Characterization of the AMP-activated protein kinase kinase from rat liver and identification of threonine 172 as the major site at which it phosphorylates AMP-activated protein kinase,” The Journal of Biological Chemistry, vol. 271, no. 44, pp. 27879–27887, 1996. View at Publisher · View at Google Scholar · View at Scopus
  34. A. Woods, K. Dickerson, R. Heath et al., “Ca2+/calmodulin-dependent protein kinase kinase-β acts upstream of AMP-activated protein kinase in mammalian cells,” Cell Metabolism, vol. 2, no. 1, pp. 21–33, 2005. View at Publisher · View at Google Scholar · View at Scopus
  35. K. A. Anderson, T. J. Ribar, F. Lin et al., “Hypothalamic CaMKK2 contributes to the regulation of energy balance,” Cell Metabolism, vol. 7, no. 5, pp. 377–388, 2008. View at Publisher · View at Google Scholar · View at Scopus
  36. M. Claret, M. A. Smith, C. Knauf et al., “Deletion of Lkb1 in pro-opiomelanocortin neurons impairs peripheral glucose homeostasis in mice,” Diabetes, vol. 60, no. 3, pp. 735–745, 2011. View at Publisher · View at Google Scholar · View at Scopus
  37. Fei-Wang, D.-R. Tian, P. Tso, and J.-S. Han, “Diet-induced obese rats exhibit impaired LKB1-AMPK signaling in hypothalamus and adipose tissue,” Peptides, vol. 35, no. 1, pp. 23–30, 2012. View at Publisher · View at Google Scholar · View at Scopus
  38. S. A. Hawley, D. A. Pan, K. J. Mustard et al., “Calmodulin-dependent protein kinase kinase-β is an alternative upstream kinase for AMP-activated protein kinase,” Cell Metabolism, vol. 2, no. 1, pp. 9–19, 2005. View at Publisher · View at Google Scholar · View at Scopus
  39. D. Carling, M. J. Sanders, and A. Woods, “The regulation of AMP-activated protein kinase by upstream kinases,” International Journal of Obesity, vol. 32, supplement 4, pp. S55–S59, 2008. View at Publisher · View at Google Scholar · View at Scopus
  40. G. Zhou, R. Myers, Y. Li et al., “Role of AMP-activated protein kinase in mechanism of metformin action,” The Journal of Clinical Investigation, vol. 108, no. 8, pp. 1167–1174, 2001. View at Publisher · View at Google Scholar · View at Scopus
  41. K. V. Doan, C. M. Ko, A. W. Kinyua et al., “Gallic acid regulates body weight and glucose homeostasis through AMPK activation,” Endocrinology, vol. 156, no. 1, pp. 157–168, 2015. View at Publisher · View at Google Scholar · View at Scopus
  42. D. M. Breen, T. Sanli, A. Giacca, and E. Tsiani, “Stimulation of muscle cell glucose uptake by resveratrol through sirtuins and AMPK,” Biochemical and Biophysical Research Communications, vol. 374, no. 1, pp. 117–122, 2008. View at Publisher · View at Google Scholar · View at Scopus
  43. Y. S. Lee, W. S. Kim, K. H. Kim et al., “Berberine, a natural plant product, activates AMP-activated protein kinase with beneficial metabolic effects in diabetic and insulin-resistant states,” Diabetes, vol. 55, no. 8, pp. 2256–2264, 2006. View at Publisher · View at Google Scholar · View at Scopus
  44. P. Pu, X.-A. Wang, M. Salim et al., “Baicalein, a natural product, selectively activating AMPKalpha(2) and ameliorates metabolic disorder in diet-induced mice,” Molecular and Cellular Endocrinology, vol. 362, no. 1-2, pp. 128–138, 2012. View at Publisher · View at Google Scholar
  45. J. Ahn, H. Lee, S. Kim, J. Park, and T. Ha, “The anti-obesity effect of quercetin is mediated by the AMPK and MAPK signaling pathways,” Biochemical and Biophysical Research Communications, vol. 373, no. 4, pp. 545–549, 2008. View at Google Scholar
  46. S.-L. Huang, R.-T. Yu, J. Gong et al., “Arctigenin, a natural compound, activates AMP-activated protein kinase via inhibition of mitochondria complex I and ameliorates metabolic disorders in ob/ob mice,” Diabetologia, vol. 55, no. 5, pp. 1469–1481, 2012. View at Publisher · View at Google Scholar · View at Scopus
  47. J.-T. Hwang, I.-J. Park, J.-I. Shin et al., “Genistein, EGCG, and capsaicin inhibit adipocyte differentiation process via activating AMP-activated protein kinase,” Biochemical and Biophysical Research Communications, vol. 338, no. 2, pp. 694–699, 2005. View at Publisher · View at Google Scholar · View at Scopus
  48. W. Pan, H. Yang, C. Cao et al., “AMPK mediates curcumin-induced cell death in CaOV3 ovarian cancer cells,” Oncology Reports, vol. 20, no. 6, pp. 1553–1559, 2008. View at Publisher · View at Google Scholar · View at Scopus
  49. N. K. LeBrasseur, M. Kelly, T.-S. Tsao et al., “Thiazolidinediones can rapidly activate AMP-activated protein kinase in mammalian tissues,” American Journal of Physiology—Endocrinology and Metabolism, vol. 291, no. 1, pp. E175–E181, 2006. View at Publisher · View at Google Scholar · View at Scopus
  50. J. M. Corton, J. G. Gillespie, S. A. Hawley, and D. G. Hardie, “5-Aminoimidazole-4-carboxamide ribonucleoside. A specific method for activating AMP-activated protein kinase in intact cells?” European Journal of Biochemistry, vol. 229, no. 2, pp. 558–565, 1995. View at Publisher · View at Google Scholar · View at Scopus
  51. B. Xiao, M. J. Sanders, E. Underwood et al., “Structure of mammalian AMPK and its regulation by ADP,” Nature, vol. 472, no. 7342, pp. 230–233, 2011. View at Publisher · View at Google Scholar · View at Scopus
  52. F. A. Ross, T. E. Jensen, and D. G. Hardie, “Differential regulation by AMP and ADP of AMPK complexes containing different γ subunit isoforms,” Biochemical Journal, vol. 473, no. 2, pp. 189–199, 2016. View at Publisher · View at Google Scholar · View at Scopus
  53. J. S. Oakhill, R. Steel, Z.-P. Chen et al., “AMPK is a direct adenylate charge-regulated protein kinase,” Science, vol. 332, no. 6036, pp. 1433–1435, 2011. View at Publisher · View at Google Scholar · View at Scopus
  54. R. R. Deshmukh and Q. P. Dou, “Proteasome inhibitors induce AMPK activation via CaMKKβ in human breast cancer cells,” Breast Cancer Research and Treatment, vol. 153, no. 1, pp. 79–88, 2015. View at Publisher · View at Google Scholar · View at Scopus
  55. Y. Xu, Y. Gu, G. Liu et al., “Cidec promotes the differentiation of human adipocytes by degradation of AMPKα through ubiquitin-proteasome pathway,” Biochimica et Biophysica Acta (BBA)—General Subjects, vol. 1850, no. 12, pp. 2552–2562, 2015. View at Publisher · View at Google Scholar · View at Scopus
  56. A. K. Al-Hakim, A. Zagorska, L. Chapman, M. Deak, M. Peggie, and D. R. Alessi, “Control of AMPK-related kinases by USP9X and atypical Lys29/Lys33-linked polyubiquitin chains,” Biochemical Journal, vol. 411, no. 2, pp. 249–260, 2008. View at Publisher · View at Google Scholar · View at Scopus
  57. C. T. Pineda, S. Ramanathan, K. Fon Tacer et al., “Degradation of AMPK by a cancer-specific ubiquitin ligase,” Cell, vol. 160, no. 4, pp. 715–728, 2015. View at Publisher · View at Google Scholar · View at Scopus
  58. J. Qi, J. Gong, T. Zhao et al., “Downregulation of AMP-activated protein kinase by Cidea-mediated ubiquitination and degradation in brown adipose tissue,” The EMBO Journal, vol. 27, no. 11, pp. 1537–1548, 2008. View at Publisher · View at Google Scholar · View at Scopus
  59. L. M. Ignacio-Souza, B. Bombassaro, L. B. Pascoal et al., “Defective regulation of the ubiquitin/proteasome system in the hypothalamus of obese male mice,” Endocrinology, vol. 155, no. 8, pp. 2831–2844, 2014. View at Publisher · View at Google Scholar · View at Scopus
  60. T. L. Martin, T. Alquier, K. Asakura, N. Furukawa, F. Preitner, and B. B. Kahn, “Diet-induced obesity alters AMP kinase activity in hypothalamus and skeletal muscle,” The Journal of Biological Chemistry, vol. 281, no. 28, pp. 18933–18941, 2006. View at Publisher · View at Google Scholar · View at Scopus
  61. T. Kadowaki and T. Yamauchi, “Adiponectin and adiponectin receptors,” Endocrine Reviews, vol. 26, no. 3, pp. 439–451, 2005. View at Publisher · View at Google Scholar · View at Scopus
  62. N. Kubota, Y. Terauchi, T. Yamauchi et al., “Disruption of adiponectin causes insulin resistance and neointimal formation,” Journal of Biological Chemistry, vol. 277, no. 29, pp. 25863–25866, 2002. View at Publisher · View at Google Scholar · View at Scopus
  63. N. Maeda, I. Shimomura, K. Kishida et al., “Diet-induced insulin resistance in mice lacking adiponectin/ACRP30,” Nature Medicine, vol. 8, no. 7, pp. 731–737, 2002. View at Publisher · View at Google Scholar · View at Scopus
  64. C. T. Lim, B. Kola, and M. Korbonits, “AMPK as a mediator of hormonal signalling,” Journal of Molecular Endocrinology, vol. 44, no. 2, pp. 87–97, 2010. View at Publisher · View at Google Scholar · View at Scopus
  65. I. Klein, M. Sanchez-Alavez, I. Tabarean et al., “AdipoR1 and 2 are expressed on warm sensitive neurons of the hypothalamic preoptic area and contribute to central hyperthermic effects of adiponectin,” Brain Research, vol. 1423, pp. 1–9, 2011. View at Publisher · View at Google Scholar · View at Scopus
  66. A. Coope, M. Milanski, E. P. Araújo et al., “AdipoR1 mediates the anorexigenic and insulin/leptin-like actions of adiponectin in the hypothalamus,” FEBS Letters, vol. 582, no. 10, pp. 1471–1476, 2008. View at Publisher · View at Google Scholar · View at Scopus
  67. N. Kubota, W. Yano, T. Kubota et al., “Adiponectin stimulates AMP-activated protein kinase in the hypothalamus and increases food intake,” Cell Metabolism, vol. 6, no. 1, pp. 55–68, 2007. View at Publisher · View at Google Scholar · View at Scopus
  68. E. Guillod-Maximin, A. F. Roy, C. M. Vacher et al., “Adiponectin receptors are expressed in hypothalamus and colocalized with proopiomelanocortin and neuropeptide Y in rodent arcuate neurons,” Journal of Endocrinology, vol. 200, no. 1, pp. 93–105, 2009. View at Publisher · View at Google Scholar · View at Scopus
  69. T. Kadowaki, T. Yamauchi, and N. Kubota, “The physiological and pathophysiological role of adiponectin and adiponectin receptors in the peripheral tissues and CNS,” FEBS Letters, vol. 582, no. 1, pp. 74–80, 2008. View at Publisher · View at Google Scholar · View at Scopus
  70. H. Shimizu, T. Tsuchiya, N. Sato, Y. Shimomura, I. Kobayashi, and M. Mori, “Troglitazone reduces plasma leptin concentration but increases hunger in NIDDM patients,” Diabetes Care, vol. 21, no. 9, pp. 1470–1474, 1998. View at Publisher · View at Google Scholar · View at Scopus
  71. M. Lehrke and M. A. Lazar, “The many faces of PPARγ,” Cell, vol. 123, no. 6, pp. 993–999, 2005. View at Publisher · View at Google Scholar · View at Scopus
  72. P. G. F. Quaresma, N. Reencober, T. M. Zanotto et al., “Pioglitazone treatment increases food intake and decreases energy expenditure partially via hypothalamic adiponectin/adipoR1/AMPK pathway,” International Journal of Obesity, vol. 40, no. 1, pp. 138–146, 2016. View at Publisher · View at Google Scholar · View at Scopus
  73. M. Kojima, H. Hosoda, Y. Date, M. Nakazato, H. Matsuo, and K. Kangawa, “Ghrelin is a growth-hormone-releasing acylated peptide from stomach,” Nature, vol. 402, no. 6762, pp. 656–660, 1999. View at Publisher · View at Google Scholar · View at Scopus
  74. A. M. Wren, L. J. Seal, M. A. Cohen et al., “Ghrelin enhances appetite and increases food intake in humans,” Journal of Clinical Endocrinology and Metabolism, vol. 86, no. 12, pp. 5992–5995, 2001. View at Publisher · View at Google Scholar · View at Scopus
  75. A. M. Wren, C. J. Small, H. L. Ward et al., “The novel hypothalamic peptide ghrelin stimulates food intake and growth hormone secretion,” Endocrinology, vol. 141, no. 11, pp. 4325–4328, 2000. View at Publisher · View at Google Scholar · View at Scopus
  76. K. Kirsz and D. A. Zieba, “Ghrelin-mediated appetite regulation in the central nervous system,” Peptides, vol. 32, no. 11, pp. 2256–2264, 2011. View at Publisher · View at Google Scholar · View at Scopus
  77. M. Lopez, R. Lage, A. K. Saha et al., “Hypothalamic fatty acid metabolism mediates the orexigenic action of ghrelin,” Cell Metabolism, vol. 7, no. 5, pp. 389–399, 2008. View at Publisher · View at Google Scholar
  78. S. Gao, N. Casals, W. Keung, T. H. Moran, and G. D. Lopaschuk, “Differential effects of central ghrelin on fatty acid metabolism in hypothalamic ventral medial and arcuate nuclei,” Physiology and Behavior, vol. 118, pp. 165–170, 2013. View at Publisher · View at Google Scholar · View at Scopus
  79. C. T. Lim, B. Kola, D. Feltrin et al., “Ghrelin and cannabinoids require the ghrelin receptor to affect cellular energy metabolism,” Molecular and Cellular Endocrinology, vol. 365, no. 2, pp. 303–308, 2013. View at Publisher · View at Google Scholar · View at Scopus
  80. P. A. Bennett, G. B. Thomas, A. D. Howard et al., “Hypothalamic growth hormone secretagogue-receptor (GHS-R) expression is regulated by growth hormone in the rat,” Endocrinology, vol. 138, no. 11, pp. 4552–4557, 1997. View at Publisher · View at Google Scholar · View at Scopus
  81. Z. B. Andrews, “Central mechanisms involved in the orexigenic actions of ghrelin,” Peptides, vol. 32, no. 11, pp. 2248–2255, 2011. View at Publisher · View at Google Scholar · View at Scopus
  82. D. Kohno, H. Sone, Y. Minokoshi, and T. Yada, “Ghrelin raises [Ca2+]i via AMPK in hypothalamic arcuate nucleus NPY neurons,” Biochemical and Biophysical Research Communications, vol. 366, no. 2, pp. 388–392, 2008. View at Publisher · View at Google Scholar
  83. Y. Yang, D. Atasoy, H. H. Su, and S. M. Sternson, “Hunger states switch a flip-flop memory circuit via a synaptic AMPK-dependent positive feedback loop,” Cell, vol. 146, no. 6, pp. 992–1003, 2011. View at Publisher · View at Google Scholar · View at Scopus
  84. N. Jamshidi and D. A. Taylor, “Anandamide administration into the ventromedial hypothalamus stimulates appetite in rats,” British Journal of Pharmacology, vol. 134, no. 6, pp. 1151–1154, 2001. View at Publisher · View at Google Scholar · View at Scopus
  85. B. Poirier, J.-P. Bidouard, C. Cadrouvele et al., “The anti-obesity effect of rimonabant is associated with an improved serum lipid profile,” Diabetes, Obesity and Metabolism, vol. 7, no. 1, pp. 65–72, 2005. View at Publisher · View at Google Scholar · View at Scopus
  86. T. C. Kirkham and C. M. Williams, “Endocannabinoid receptor antagonists: potential for obesity treatment,” Treatments in Endocrinology, vol. 3, no. 6, pp. 345–360, 2004. View at Publisher · View at Google Scholar · View at Scopus
  87. B. Kola, E. Hubina, S. A. Tucci et al., “Cannabinoids and ghrelin have both central and peripheral metabolic and cardiac effects via AMP-activated protein kinase,” The Journal of Biological Chemistry, vol. 280, no. 26, pp. 25196–25201, 2005. View at Publisher · View at Google Scholar · View at Scopus
  88. A. Borgquist, C. Meza, and E. J. Wagner, “The role of AMP-activated protein kinase in the androgenic potentiation of cannabinoid-induced changes in energy homeostasis,” American Journal of Physiology—Endocrinology and Metabolism, vol. 308, no. 6, pp. E482–E495, 2015. View at Publisher · View at Google Scholar · View at Scopus
  89. V. Di Marzo, S. K. Goparaju, L. Wang et al., “Leptin-regulated endocannabinoids are involved in maintaining food intake,” Nature, vol. 410, no. 6830, pp. 822–825, 2001. View at Publisher · View at Google Scholar · View at Scopus
  90. B. Kola, I. Farkas, M. Christ-Crain et al., “The orexigenic effect of ghrelin is mediated through central activation of the endogenous cannabinoid system,” PLoS ONE, vol. 3, no. 3, Article ID e1797, 2008. View at Publisher · View at Google Scholar · View at Scopus
  91. P. A. Tataranni, D. E. Larson, S. Snitker, J. B. Young, J. P. Flatt, and E. Ravussin, “Effects of glucocorticoids on energy metabolism and food intake in humans,” American Journal of Physiology—Endocrinology and Metabolism, vol. 271, no. 2, part 1, pp. E317–E325, 1996. View at Google Scholar · View at Scopus
  92. M. Christ-Crain, B. Kola, F. Lolli et al., “AMP-activated protein kinase mediates glucocorticoid-induced metabolic changes: a novel mechanism in Cushing's syndrome,” The FASEB Journal, vol. 22, no. 6, pp. 1672–1683, 2008. View at Publisher · View at Google Scholar · View at Scopus
  93. S. Di, R. Malcher-Lopes, V. L. Marcheselli, N. G. Bazan, and J. G. Tasker, “Rapid glucocorticoid-mediated endocannabinoid release and opposing regulation of glutamate and γ-aminobutyric acid inputs to hypothalamic magnocellular neurons,” Endocrinology, vol. 146, no. 10, pp. 4292–4301, 2005. View at Publisher · View at Google Scholar · View at Scopus
  94. M. Scerif, T. Füzesi, J. D. Thomas et al., “CB1 receptor mediates the effects of glucocorticoids on AMPK activity in the hypothalamus,” Journal of Endocrinology, vol. 219, no. 1, pp. 79–88, 2013. View at Publisher · View at Google Scholar · View at Scopus
  95. H. Shimizu, H. Arima, M. Watanabe et al., “Glucocorticoids increase neuropeptide Y and agouti-related peptide gene expression via adenosine monophosphate-activated protein kinase signaling in the arcuate nucleus of rats,” Endocrinology, vol. 149, no. 9, pp. 4544–4553, 2008. View at Publisher · View at Google Scholar · View at Scopus
  96. L. Liu, Z. Song, H. Jiao, and H. Lin, “Glucocorticoids increase NPY gene expression via hypothalamic AMPK signaling in broiler chicks,” Endocrinology, vol. 155, no. 6, pp. 2190–2198, 2014. View at Publisher · View at Google Scholar · View at Scopus
  97. R. J. McCrimmon, X. Fan, Y. Ding, W. Zhu, R. J. Jacob, and R. S. Sherwin, “Potential role for AMP-activated protein kinase in hypoglycemia sensing in the ventromedial hypothalamus,” Diabetes, vol. 53, no. 8, pp. 1953–1958, 2004. View at Publisher · View at Google Scholar · View at Scopus
  98. M.-S. Kim, J.-Y. Park, C. Namkoong et al., “Anti-obesity effects of α-lipoic acid mediated by suppression of hypothalamic AMP-activated protein kinase,” Nature Medicine, vol. 10, no. 7, pp. 727–733, 2004. View at Publisher · View at Google Scholar · View at Scopus
  99. T. Alquier, J. Kawashima, Y. Tsuji, and B. B. Kahn, “Role of hypothalamic adenosine 5′-monophosphate-activated protein kinase in the impaired counterregulatory response induced by repetitive neuroglucopenia,” Endocrinology, vol. 148, no. 3, pp. 1367–1375, 2007. View at Publisher · View at Google Scholar · View at Scopus
  100. R. J. McCrimmon, M. Shaw, X. Fan et al., “Key Role for AMP-activated protein kinase in the ventromedial hypothalamus in regulating counterregulatory hormone responses to acute hypoglycemia,” Diabetes, vol. 57, no. 2, pp. 444–450, 2008. View at Publisher · View at Google Scholar · View at Scopus
  101. X. Fan, Y. Ding, S. Brown et al., “Hypothalamic AMP-activated protein kinase activation with AICAR amplifies counterregulatory responses to hypoglycemia in a rodent model of type 1 diabetes,” American Journal of Physiology—Regulatory Integrative and Comparative Physiology, vol. 296, no. 6, pp. R1702–R1708, 2009. View at Publisher · View at Google Scholar · View at Scopus
  102. S. R. Salpeter, J. M. E. Walsh, T. M. Ormiston, E. Greyber, N. S. Buckley, and E. E. Salpeter, “Meta-analysis: effect of hormone-replacement therapy on components of the metabolic syndrome in postmenopausal women,” Diabetes, Obesity and Metabolism, vol. 8, no. 5, pp. 538–554, 2006. View at Publisher · View at Google Scholar · View at Scopus
  103. F. S. J. De Souza, S. Nasif, R. López-Leal, D. H. Levi, M. J. Low, and M. Rubinsten, “The estrogen receptor α colocalizes with proopiomelanocortin in hypothalamic neurons and binds to a conserved motif present in the neuron-specific enhancer nPE2,” European Journal of Pharmacology, vol. 660, no. 1, pp. 181–187, 2011. View at Publisher · View at Google Scholar · View at Scopus
  104. T. A. Roepke, “Oestrogen modulates hypothalamic control of energy homeostasis through multiple mechanisms,” Journal of Neuroendocrinology, vol. 21, no. 2, pp. 141–150, 2009. View at Publisher · View at Google Scholar · View at Scopus
  105. P. B. Martínez de Morentin, I. González-García, L. Martins et al., “Estradiol regulates brown adipose tissue thermogenesis via hypothalamic AMPK,” Cell Metabolism, vol. 20, no. 1, pp. 41–53, 2014. View at Publisher · View at Google Scholar · View at Scopus
  106. Y.-C. Tsai, Y.-M. Lee, K.-K. Lam, Y.-C. Wu, M.-H. Yen, and P.-Y. Cheng, “The role of hypothalamic AMP-activated protein kinase in ovariectomy-induced obesity in rats,” Menopause, vol. 17, no. 6, pp. 1194–1200, 2010. View at Publisher · View at Google Scholar · View at Scopus
  107. B. A. Ibrahim, P. Tamrakar, A. D. Gujar, A. K. Cherian, and K. P. Briski, “Caudal fourth ventricular administration of the AMPK activator 5-aminoimidazole-4-carboxamide-riboside regulates glucose and counterregulatory hormone profiles, dorsal vagal complex metabolosensory neuron function, and hypothalamic fos expression,” Journal of Neuroscience Research, vol. 91, no. 9, pp. 1226–1238, 2013. View at Publisher · View at Google Scholar · View at Scopus
  108. P. Tamrakar and K. P. Briski, “Estradiol regulation of hypothalamic astrocyte adenosine 5′-monophosphate-activated protein kinase activity: role of hindbrain catecholamine signaling,” Brain Research Bulletin, vol. 110, pp. 47–53, 2015. View at Publisher · View at Google Scholar · View at Scopus
  109. P. B. Martínez de Morentin, R. Lage, I. González-García et al., “Pregnancy induces resistance to the anorectic effect of hypothalamic malonyl-COA and the thermogenic effect of hypothalamic AMPK inhibition in female rats,” Endocrinology, vol. 156, no. 3, pp. 947–960, 2015. View at Publisher · View at Google Scholar · View at Scopus
  110. Y. Minokoshi, Y.-B. Kim, O. D. Peroni et al., “Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase,” Nature, vol. 415, no. 6869, pp. 339–343, 2002. View at Publisher · View at Google Scholar · View at Scopus
  111. U. Andersson, K. Filipsson, C. R. Abbott et al., “AMP-activated protein kinase plays a role in the control of food intake,” The Journal of Biological Chemistry, vol. 279, no. 13, pp. 12005–12008, 2004. View at Publisher · View at Google Scholar · View at Scopus
  112. M. Tanida, N. Yamamoto, T. Shibamoto, and K. Rahmouni, “Involvement of hypothalamic AMP-activated protein kinase in leptin-induced sympathetic nerve activation,” PLoS ONE, vol. 8, no. 2, article e56660, 2013. View at Publisher · View at Google Scholar · View at Scopus
  113. M. A. Cowley, J. L. Smart, M. Rubinstein et al., “Leptin activates anorexigenic POMC neurons through a neural network in the arcuate nucleus,” Nature, vol. 411, no. 6836, pp. 480–484, 2001. View at Publisher · View at Google Scholar · View at Scopus
  114. S. Obici, B. B. Zhang, G. Karkanias, and L. Rossetti, “Hypothalamic insulin signaling is required for inhibition of glucose production,” Nature Medicine, vol. 8, no. 12, pp. 1376–1382, 2002. View at Publisher · View at Google Scholar · View at Scopus
  115. C. S. Solon, D. Franci, L. M. Ignacio-Souza et al., “Taurine enhances the anorexigenic effects of insulin in the hypothalamus of rats,” Amino Acids, vol. 42, no. 6, pp. 2403–2410, 2012. View at Publisher · View at Google Scholar · View at Scopus
  116. C. Namkoong, S. K. Min, G. J. Pil et al., “Enhanced hypothalamic AMP-activated protein kinase activity contributes to hyperphagia in diabetic rats,” Diabetes, vol. 54, no. 1, pp. 63–68, 2005. View at Publisher · View at Google Scholar · View at Scopus
  117. S.-M. Han, C. Namkoong, P. G. Jang et al., “Hypothalamic AMP-activated protein kinase mediates counter-regulatory responses to hypoglycaemia in rats,” Diabetologia, vol. 48, no. 10, pp. 2170–2178, 2005. View at Publisher · View at Google Scholar · View at Scopus
  118. I. Shimizu, M. Hirota, C. Ohboshi, and K. Shima, “Identification and localization of glucagon-like peptide-1 and its receptor in rat brain,” Endocrinology, vol. 121, no. 3, pp. 1076–1082, 1987. View at Publisher · View at Google Scholar · View at Scopus
  119. M. D. Turton, D. O'Shea, I. Gunn et al., “A role for glucagon-like peptide-1 in the central regulation of feeding,” Nature, vol. 379, no. 6560, pp. 69–72, 1996. View at Publisher · View at Google Scholar · View at Scopus
  120. A. P. Goldstone, I. Morgan, J. G. Mercer et al., “Effect of leptin on hypothalamic GLP-1 peptide and brain-stem pre-proglucagon mRNA,” Biochemical and Biophysical Research Communications, vol. 269, no. 2, pp. 331–335, 2000. View at Publisher · View at Google Scholar · View at Scopus
  121. V. Hurtado-Carneiro, C. Sanz, I. Roncero, P. Vazquez, E. Blazquez, and E. Alvarez, “Glucagon-like peptide 1 (GLP-1) can reverse AMP-activated protein kinase (AMPK) and S6 kinase (P70S6K) activities induced by fluctuations in glucose levels in hypothalamic areas involved in feeding behaviour,” Molecular Neurobiology, vol. 45, no. 2, pp. 348–361, 2012. View at Publisher · View at Google Scholar · View at Scopus
  122. P.-E. Poleni, S. Akieda-Asai, S. Koda et al., “Possible involvement of melanocortin-4-receptor and AMP-activated protein kinase in the interaction of glucagon-like peptide-1 and leptin on feeding in rats,” Biochemical and Biophysical Research Communications, vol. 420, no. 1, pp. 36–41, 2012. View at Publisher · View at Google Scholar · View at Scopus
  123. D. Beiroa, M. Imbernon, R. Gallego et al., “GLP-1 agonism stimulates brown adipose tissue thermogenesis and browning through hypothalamic AMPK,” Diabetes, vol. 63, no. 10, pp. 3346–3358, 2014. View at Publisher · View at Google Scholar · View at Scopus
  124. M. López, C. Diéguez, and R. Nogueiras, “Hypothalamic GLP-1: the control of BAT thermogenesis and browning of white fat,” Adipocyte, vol. 4, no. 2, pp. 141–145, 2015. View at Publisher · View at Google Scholar
  125. N. Fujii, T. Hayashi, M. F. Hirshman et al., “Exercise induces isoform-specific increase in 5' AMP-activated protein kinase activity in human skeletal muscle,” Biochemical and Biophysical Research Communications, vol. 273, no. 3, pp. 1150–1155, 2000. View at Publisher · View at Google Scholar · View at Scopus
  126. U. Andersson, J. T. Treebak, J. N. Nielsen et al., “Exercise in rats does not alter hypothalamic AMP-activated protein kinase activity,” Biochemical and Biophysical Research Communications, vol. 329, no. 2, pp. 719–725, 2005. View at Publisher · View at Google Scholar · View at Scopus
  127. S. Park, S. J. Jin, W. J. Dong, and M. H. Sang, “Exercise enhances insulin and leptin signaling in the cerebral cortex and hypothalamus during dexamethasone-induced stress in diabetic rats,” Neuroendocrinology, vol. 82, no. 5-6, pp. 282–293, 2006. View at Publisher · View at Google Scholar · View at Scopus
  128. E. R. Ropelle, M. F. A. Fernandes, M. B. S. Flores et al., “Central exercise action increases the AMPK and mTOR response to leptin,” PLoS ONE, vol. 3, no. 12, Article ID e3856, 2008. View at Publisher · View at Google Scholar · View at Scopus
  129. M. Claret, M. A. Smith, R. L. Batterham et al., “AMPK is essential for energy homeostasis regulation and glucose sensing by POMC and AgRP neurons,” The Journal of Clinical Investigation, vol. 117, no. 8, pp. 2325–2336, 2007. View at Publisher · View at Google Scholar · View at Scopus
  130. D. G. Hardie, F. A. Ross, and S. A. Hawley, “AMPK: a nutrient and energy sensor that maintains energy homeostasis,” Nature Reviews Molecular Cell Biology, vol. 13, no. 4, pp. 251–262, 2012. View at Publisher · View at Google Scholar · View at Scopus
  131. D. Kohno, H. Sone, S. Tanaka, H. Kurita, D. Gantulga, and T. Yada, “AMP-activated protein kinase activates neuropeptide Y neurons in the hypothalamic arcuate nucleus to increase food intake in rats,” Neuroscience Letters, vol. 499, no. 3, pp. 194–198, 2011. View at Publisher · View at Google Scholar · View at Scopus
  132. T. M. Loftus, D. E. Jaworsky, C. L. Frehywot et al., “Reduced food intake and body weight in mice treated with fatty acid synthase inhibitors,” Science, vol. 288, no. 5475, pp. 2379–2381, 2000. View at Publisher · View at Google Scholar · View at Scopus
  133. J. L. Beverly and R. J. Martin, “Influence of fatty acid oxidation in lateral hypothalamus on food intake and body composition,” American Journal of Physiology—Regulatory Integrative and Comparative Physiology, vol. 261, no. 2, part 2, pp. R339–R343, 1991. View at Google Scholar · View at Scopus
  134. T. R. Kasser and R. J. Martin, “Induction of ventrolateral hypothalamic fatty acid oxidation in diabetic rats,” Physiology and Behavior, vol. 36, no. 2, pp. 385–388, 1986. View at Publisher · View at Google Scholar · View at Scopus
  135. Z. Hu, S. H. Cha, S. Chohnan, and M. D. Lane, “Hypothalamic malonyl-CoA as a mediator of feeding behavior,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 22, pp. 12624–12629, 2003. View at Publisher · View at Google Scholar · View at Scopus
  136. S. Obici, Z. Feng, A. Arduini, R. Conti, and L. Rossetti, “Inhibition of hypothalamic carnitine palmitoyltransferase-1 decreases food intake and glucose production,” Nature Medicine, vol. 9, no. 6, pp. 756–761, 2003. View at Publisher · View at Google Scholar · View at Scopus
  137. Z. Hu, Y. Dai, M. Prentki, S. Chohnan, and M. D. Lane, “A role for hypothalamic malonyl-CoA in the control of food intake,” The Journal of Biological Chemistry, vol. 280, no. 48, pp. 39681–39683, 2005. View at Publisher · View at Google Scholar · View at Scopus
  138. M. J. Wolfgang and M. D. Lane, “The role of hypothalamic malonyl-CoA in energy homeostasis,” Journal of Biological Chemistry, vol. 281, no. 49, pp. 37265–37269, 2006. View at Publisher · View at Google Scholar · View at Scopus
  139. M. J. Wolfgang, S. H. Cha, D. S. Millington et al., “Brain-specific carnitine palmitoyl-transferase-1c: role in CNS fatty acid metabolism, food intake, and body weight,” Journal of Neurochemistry, vol. 105, no. 4, pp. 1550–1559, 2008. View at Publisher · View at Google Scholar · View at Scopus
  140. S. Ramírez, L. Martins, J. Jacas et al., “Hypothalamic ceramide levels regulated by CPT1C mediate the orexigenic effect of ghrelin,” Diabetes, vol. 62, no. 7, pp. 2329–2337, 2013. View at Publisher · View at Google Scholar · View at Scopus
  141. R. Lage, M. J. Vázquez, L. Varela et al., “Ghrelin effects on neuropeptides in the rat hypothalamus depend on fatty acid metabolism actions on BSX but not on gender,” The FASEB Journal, vol. 24, no. 8, pp. 2670–2679, 2010. View at Publisher · View at Google Scholar · View at Scopus
  142. Z. Song, L. Liu, Y. Yue et al., “Fasting alters protein expression of AMP-activated protein kinase in the hypothalamus of broiler chicks (Gallus gallus domesticus),” General and Comparative Endocrinology, vol. 178, no. 3, pp. 546–555, 2012. View at Publisher · View at Google Scholar · View at Scopus
  143. L. Lei and Z. Lixian, “Effect of 24 h fasting on gene expression of AMPK, appetite regulation peptides and lipometabolism related factors in the hypothalamus of broiler chicks,” Asian-Australasian Journal of Animal Sciences, vol. 25, no. 9, pp. 1300–1308, 2012. View at Publisher · View at Google Scholar · View at Scopus
  144. D. Cota, K. Proulx, K. A. Blake Smith et al., “Hypothalamic mTOR signaling regulates food intake,” Science, vol. 312, no. 5775, pp. 927–930, 2006. View at Publisher · View at Google Scholar · View at Scopus
  145. K. Inoki, T. Zhu, and K.-L. Guan, “TSC2 mediates cellular energy response to control cell growth and survival,” Cell, vol. 115, no. 5, pp. 577–590, 2003. View at Publisher · View at Google Scholar · View at Scopus
  146. M. P. Byfield, J. T. Murray, and J. M. Backer, “hVps34 is a nutrient-regulated lipid kinase required for activation of p70 S6 kinase,” The Journal of Biological Chemistry, vol. 280, no. 38, pp. 33076–33082, 2005. View at Publisher · View at Google Scholar · View at Scopus
  147. Y. Dagon, E. Hur, B. Zheng, K. Wellenstein, L. C. Cantley, and B. B. Kahn, “P70S6 kinase phosphorylates AMPK on serine 491 to mediate leptin's effect on food intake,” Cell Metabolism, vol. 16, no. 1, pp. 104–112, 2012. View at Publisher · View at Google Scholar · View at Scopus
  148. E. R. Ropelle, J. R. Pauli, M. F. A. Fernandes et al., “A central role for neuronal AMP-activated protein kinase (AMPK) and mammalian target of rapamyein (mTOR) in high-protein diet-induced weight loss,” Diabetes, vol. 57, no. 3, pp. 594–605, 2008. View at Publisher · View at Google Scholar · View at Scopus
  149. B. B. Lowell and B. M. Spiegelman, “Towards a molecular understanding of adaptive thermogenesis,” Nature, vol. 404, no. 6778, pp. 652–660, 2000. View at Google Scholar · View at Scopus
  150. M. N. Perkins, N. J. Rothwell, M. J. Stock, and T. W. Stone, “Activation of brown adipose tissue thermogenesis by the ventromedial hypothalamus,” Nature, vol. 289, no. 5796, pp. 401–402, 1981. View at Publisher · View at Google Scholar · View at Scopus
  151. S. J. Holt, H. V. Wheal, and D. A. York, “Hypothalamic control of brown adipose tissue in Zucker lean and obese rats. Effect of electrical stimulation of the ventromedial nucleus and other hypothalamic centres,” Brain Research, vol. 405, no. 2, pp. 227–233, 1987. View at Publisher · View at Google Scholar · View at Scopus
  152. T. Yoshida and G. A. Bray, “Catecholamine turnover in rats with ventromedial hypothalamic lesions,” American Journal of Physiology, vol. 246, no. 4, part 2, pp. R558–R565, 1984. View at Google Scholar · View at Scopus
  153. M. Saito, Y. Minokoshi, and T. Shimazu, “Ventromedial hypothalamic stimulation accelerates norepinephrine turnover in brown adipose tissue of rats,” Life Sciences, vol. 41, no. 2, pp. 193–197, 1987. View at Publisher · View at Google Scholar · View at Scopus
  154. T. Hugie, I. Halvorson, and J. Thornhill, “Brown adipose tissue temperature responses following electrical stimulation of ventromedial hypothalamic and lateral preoptic areas or after norepinephrine infusion to long evans or sprague-dawley rats,” Brain Research, vol. 575, no. 1, pp. 57–62, 1992. View at Publisher · View at Google Scholar · View at Scopus
  155. K. W. Kim, L. Zhao, J. Donato Jr. et al., “Steroidogenic factor 1 directs programs regulating diet-induced thermogenesis and leptin action in the ventral medial hypothalamic nucleus,” Proceedings of the National Academy of Sciences of the United States of America, vol. 108, no. 26, pp. 10673–10678, 2011. View at Publisher · View at Google Scholar · View at Scopus
  156. K. W. Kim, J. Donato Jr., E. D. Berglund et al., “FOXO1 in the ventromedial hypothalamus regulates energy balance,” The Journal of Clinical Investigation, vol. 122, no. 7, pp. 2578–2589, 2012. View at Publisher · View at Google Scholar · View at Scopus
  157. S. F. Morrison, “RVLM and raphe differentially regulate sympathetic outflows to splanchnic and brown adipose tissue,” American Journal of Physiology—Regulatory Integrative and Comparative Physiology, vol. 276, no. 4, pp. R962–R973, 1999. View at Google Scholar · View at Scopus
  158. T. Uno and M. Shibata, “Role of inferior olive and thoracic IML neurons in nonshivering thermogenesis in rats,” American Journal of Physiology—Regulatory Integrative and Comparative Physiology, vol. 280, no. 2, pp. R536–R546, 2001. View at Google Scholar · View at Scopus
  159. M. Shibata, T. Uno, and M. Hashimoto, “Disinhibition of lower midbrain neurons enhances non-shivering thermogenesis in anesthetized rats,” Brain Research, vol. 833, no. 2, pp. 242–250, 1999. View at Publisher · View at Google Scholar · View at Scopus
  160. M. López, L. Varela, M. J. Vázquez et al., “Hypothalamic AMPK and fatty acid metabolism mediate thyroid regulation of energy balance,” Nature Medicine, vol. 16, no. 9, pp. 1001–1008, 2010. View at Publisher · View at Google Scholar
  161. A. J. Whittle, S. Carobbio, L. Martins et al., “BMP8B increases brown adipose tissue thermogenesis through both central and peripheral actions,” Cell, vol. 149, no. 4, pp. 871–885, 2012. View at Publisher · View at Google Scholar · View at Scopus
  162. P. Seoane-Collazo, P. B. Martínez de Morentin, J. Fernø, C. Diéguez, R. Nogueiras, and M. López, “Nicotine improves obesity and hepatic steatosis and ER stress in diet-induced obese male rats,” Endocrinology, vol. 155, no. 5, pp. 1679–1689, 2014. View at Publisher · View at Google Scholar · View at Scopus
  163. C. S. Yang, C. K. L. Lam, M. Chari et al., “Hypothalamic AMP-activated protein kinase regulates glucose production,” Diabetes, vol. 59, no. 10, pp. 2435–2443, 2010. View at Publisher · View at Google Scholar · View at Scopus
  164. M. Ikegami, H. Ikeda, T. Ohashi et al., “Olanzapine increases hepatic glucose production through the activation of hypothalamic adenosine 5′-monophosphate-activated protein kinase,” Diabetes, Obesity and Metabolism, vol. 15, no. 12, pp. 1128–1135, 2013. View at Publisher · View at Google Scholar · View at Scopus
  165. B. Brunmair, K. Staniek, F. Gras et al., “Thiazolidinediones, like metformin, inhibit respiratory complex I: a common mechanism contributing to their antidiabetic actions?” Diabetes, vol. 53, no. 4, pp. 1052–1059, 2004. View at Publisher · View at Google Scholar · View at Scopus
  166. L. G. D. Fryer, A. Parbu-Patel, and D. Carling, “The anti-diabetic drugs rosiglitazone and metformin stimulate AMP-activated protein kinase through distinct signaling pathways,” Journal of Biological Chemistry, vol. 277, no. 28, pp. 25226–25232, 2002. View at Publisher · View at Google Scholar · View at Scopus
  167. W. Sun, T.-S. Lee, M. Zhu et al., “Statins activate AMP-activated protein kinase in vitro and in vivo,” Circulation, vol. 114, no. 24, pp. 2655–2662, 2006. View at Publisher · View at Google Scholar · View at Scopus